TRxADE HEALTH, Inc. (MEDS)
NASDAQ: MEDS · IEX Real-Time Price · USD
5.93
-0.28 (-4.51%)
Apr 26, 2024, 9:53 AM EDT - Market open

TRxADE HEALTH Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013
Revenue
8.2710.259.8917.127.443.832.932.482.911.5
Upgrade
Revenue Growth (YoY)
-19.30%3.65%-42.24%130.26%94.07%30.72%18.11%-14.79%94.66%56.53%
Upgrade
Cost of Revenue
5.674.735.1411.422.570.45000.190.44
Upgrade
Gross Profit
2.65.524.755.714.873.382.932.482.721.06
Upgrade
Selling, General & Admin
7.026.16.447.494.383.472.543.492.862.49
Upgrade
Research & Development
1.380.990.90000000
Upgrade
Other Operating Expenses
1.471.342.70.730.3700000
Upgrade
Operating Expenses
9.868.4410.048.214.753.472.543.492.862.49
Upgrade
Operating Income
-7.26-2.92-5.29-2.510.13-0.090.4-1.01-0.14-1.43
Upgrade
Interest Expense / Income
1.20.340.020.030.050.060.160.150.120
Upgrade
Other Expense / Income
9.380.22--0.36-0.15-0.051.60.860.58
Upgrade
Pretax Income
-17.84-3.47-5.32-2.54-0.280.010.29-2.76-1.12-2.01
Upgrade
Net Income
-17.84-3.47-5.32-2.54-0.280.010.29-2.76-1.12-2.01
Upgrade
Net Income Growth
------96.87%----
Upgrade
Shares Outstanding (Basic)
1111000000
Upgrade
Shares Outstanding (Diluted)
2111000000
Upgrade
Shares Change
320.30%4.45%5.60%29.96%1.76%2.56%8.06%0.73%4.98%111.54%
Upgrade
EPS (Basic)
-23.36-6.15-9.75-4.95-0.75-0.90-8.10-3.60-6.30
Upgrade
EPS (Diluted)
-7.49-6.13-9.75-4.95-0.75-0.90-8.10-3.60-6.30
Upgrade
Free Cash Flow
-2.07-1.56-2.59-2.250.060.260.17-0.50.09-1.06
Upgrade
Free Cash Flow Per Share
-2.71-2.77-4.77-4.380.150.720.48-1.440.26-3.21
Upgrade
Gross Margin
31.41%53.85%47.99%33.33%65.50%88.28%100.00%100.00%93.48%70.59%
Upgrade
Operating Margin
-87.80%-28.45%-53.51%-14.64%1.68%-2.29%13.48%-40.59%-4.71%-95.67%
Upgrade
Profit Margin
-215.70%-33.87%-53.75%-14.81%-3.82%0.24%9.86%-111.21%-38.36%-134.47%
Upgrade
Free Cash Flow Margin
-25.07%-15.26%-26.18%-13.15%0.80%6.74%5.86%-20.29%3.10%-71.15%
Upgrade
EBITDA
-15.6-2.94-5.15-2.4-0.140.070.45-2.61-0.99-2
Upgrade
EBITDA Margin
-188.53%-28.69%-52.11%-14.04%-1.84%1.74%15.22%-105.11%-34.12%-133.88%
Upgrade
Depreciation & Amortization
1.050.190.140.10.0900000
Upgrade
EBIT
-16.65-3.14-5.29-2.51-0.230.070.45-2.61-1-2.01
Upgrade
EBIT Margin
-201.22%-30.59%-53.51%-14.64%-3.11%1.74%15.22%-105.11%-34.25%-134.20%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).